Praxis Precision Medicines, Inc. 10-K

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Certain Information Regarding the Trading of Our Common Stock Our common stock trades under the symbol “PRAX” on the Nasdaq Global Select Market. Holders of Our Common Stock As of February 3, 2023, there were approximately three holders of record of shares of our common stock. The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees. Dividend Policy We have never declared or paid any cash dividends on our capital stock. We currently intend to retain any future earnings to fund the development and expansion of our business, and therefore we do not anticipate paying cash dividends on our common stock in the foreseeable future. Recent Sales of Unregistered Securities We did not make any sales of unregistered securities during the three months ended December 31, 2022. Use of Proceeds from Initial Public Offering In October 2020, we completed the initial public offering of our common stock, or IPO, pursuant to which we issued and sold 11,500,000 shares of our common stock at a price to the public of $19.00 per share. All of the shares issued and sold in the IPO were registered under the Securities Act pursuant to a Registration Statement on Form S-1 (File No. 333-249074), which was declared effective by the Securities and Exchange Commission on October 15, 2020. As of December 31, 2022, we had used all of the net proceeds from the IPO. Purchases of Equity Securities by the Issuer and Affiliated Purchasers There were no repurchases of shares of common stock made during the three months ended December 31, 2022. Item 6. Selected Financial Data Reserved. 83 Table of Contents